Applied Clinical Trials podcast

ACT Brief: China’s Startup Timelines, AI-Drafted Clinical Study Reports, and Bimzelx Psoriatic Arthritis Data

0:00
1:47
Rewind 15 seconds
Fast Forward 15 seconds
In today’s ACT Brief, we examine how China’s trial startup timelines compare with those in the US and Europe, whether AI-drafted clinical study reports speed drug development, and how Bimzelx compared with Skyrizi in psoriatic arthritis.

More episodes from "Applied Clinical Trials"